Innovation doesn’t guarantee access. Payor coverage does. Manufacturers are developing extraordinary...
The global healthcare product pipeline is increasingly focusing on specialty and orphan drugs, with ...
The part of the portfolio many programs miss Copay programs are built around pharmacy claims, becaus...